Invention Grant
![Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators](/docs/US/2023-09-19/US11759455B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators
-
Application No.: US17474631Application Date: 2021-09-14
-
Publication No.: US11759455B2Publication Date: 2023-09-19
- Inventor: Christa C. Chrovian , Michael A. Letavic , Jason C. Rech , Dale A. Rudolph , Akinola Soyode-Johnson , Brice M. Stenne , Jessica L. Wall
- Applicant: JANSSEN PHARMACEUTICA NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee Address: BE Beerse
- Agency: Biospark Intellectual Property Law
- Main IPC: A61K31/4188
- IPC: A61K31/4188 ; A61P25/24 ; A61K31/12 ; C07D401/02 ; C07D205/02 ; C07D207/08
![Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators](/abs-image/US/2023/09/19/US11759455B2/abs.jpg.150x150.jpg)
Abstract:
Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.
Public/Granted literature
- US20230000833A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Public/Granted day:2023-01-05
Information query
IPC分类:
